ArticleTherapeutic advances in chronic disease2021

Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis.

Seungwon Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.